| Design and evaluation of scFv-RTX-A as a novel immunotoxin for breast cancer treatment: an in silico approach S Samavarchi Tehrani, S Gharibi, A Movahedpour, G Goodarzi, Z Jamali, ... Journal of Immunoassay and Immunochemistry 42 (1), 19-33, 2021 | 16 | 2021 |
| Targeted therapy in coronavirus disease 2019 (COVID-19): Implication from cell and gene therapy to immunotherapy and vaccine M Shirzad, M Nourigorji, A Sajedi, M Ranjbar, F Rasti, Z Sourani, ... International Immunopharmacology 111, 109161, 2022 | 13 | 2022 |
| B-Cell Epitope Mapping from Eight Antigens of Candida albicans to Design a Novel Diagnostic Kit: An Immunoinformatics Approach F Vahedi, Y Ghasemi, A Atapour, K Zomorodian, M Ranjbar, A Monabati, ... International Journal of Peptide Research and Therapeutics 28 (4), 110, 2022 | 10 | 2022 |
| Dystrophin gene editing by CRISPR/Cas9 system in human skeletal muscle cell line (HSkMC) M Dara, V Razban, M Mazloomrezaei, M Ranjbar, M Nourigorji, ... Iranian Journal of Basic Medical Sciences 24 (8), 1153, 2021 | 6 | 2021 |
| Development of a recombinant nucleocapsid protein‐based ELISA for the detection of IgM and IgG antibodies to SARS‐CoV‐2 M Ranjbar, M Asadi, M Nourigorji, B Sarkari, Z Mostafavi‐Pour, ... Biotechnology and Applied Biochemistry 69 (6), 2592-2598, 2022 | 5 | 2022 |
| B2M gene knockout in HEK293T cells by non-viral delivery of CRISPR-Cas9 system for the generation of universal cells M Ranjbar, F Amiri, M Nourigorji, F Torabizadeh, M Dara, M Dianatpour Egyptian Journal of Medical Human Genetics 23 (1), 62, 2022 | 4 | 2022 |
| HLA-A gene knockout using CRISPR/Cas9 system toward overcoming transplantation concerns F Amiri, M Ranjbar, M Pirouzfar, M Nourigorji, M Dianatpour Egyptian Journal of Medical Human Genetics 22, 1-8, 2021 | 4 | 2021 |
| B2M gene knockout in HEK293T cells by non-viral delivery of CRISPR-Cas9 for the induction of universal cell M Ranjbar, F Amiri, M Nourigorji, F Torabizadeh, M Dara, M Dianatpour | | 2021 |
